Most surveyed individuals with obesity support lower-cost options for weight maintenance, which would allow better coverage for injectable incretin mimetics for weight management during active weight loss.
Eli W. Carter, MPH
Advertisement
Articles by Eli W. Carter, MPH
The high cost of incretin mimetics for weight management limits insurance coverage and potentiates variation in utilization management strategies to control near-term spending.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
The True Cost of Running a Community CAR T-Cell Program
2
Bringing CAR T-Cell Therapy Into Community Cancer Centers
3
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials
4
Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI
5